Search hospitals > Maryland > Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center
Claim this profileBaltimore, Maryland 21205
Global Leader in Thyroid Cancer
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Cancer
Conducts research for Uterine Tumors
1104 reported clinical trials
85 medical researchers
Summary
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Thyroid Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Cancer, Uterine Tumors and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 815 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage I
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderPhiladelphia chromosome positive
Stage II
HLA-A negative
Top PIs
Kenneth J. CohenJohns Hopkins University/Sidney Kimmel Cancer Center7 years of reported clinical research
Expert in Cerebral Gliomas
Expert in Brain Tumor
52 reported clinical trials
98 drugs studied
Nilofer S. AzadJohns Hopkins University/Sidney Kimmel Cancer Center7 years of reported clinical research
Studies Cholangiocarcinoma
Studies Bile Duct Cancer
15 reported clinical trials
29 drugs studied
Michael J. PishvaianSibley Memorial Hospital4 years of reported clinical research
Studies Pancreatic Cancer
Studies Uterine Tumors
17 reported clinical trials
37 drugs studied
Channing Paller, MDSibley Memorial Hospital2 years of reported clinical research
Expert in Prostate Cancer
Studies Stomach Cancer
12 reported clinical trials
24 drugs studied
Clinical Trials running at Johns Hopkins University/Sidney Kimmel Cancer Center
Breast Cancer
Ovarian Cancer
Prostate Cancer
Thyroid Cancer
Lung Cancer
Bladder Cancer
Brain Tumor
Cancer
Acute Myeloid Leukemia
Cervical Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Johns Hopkins University/Sidney Kimmel Cancer Center?
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Thyroid Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Cancer, Uterine Tumors and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 815 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.
Where is Johns Hopkins University/Sidney Kimmel Cancer Center located?
The Johns Hopkins Kimmel Cancer Center is situated in the Weinberg Building on Broadway Street, Baltimore, MD. For access, proceed on Broadway, then turn right onto Jefferson Street after Orleans Street.
Who should I call to ask about financial aid or insurance network?
**Johns Hopkins University/Sidney Kimmel Cancer Center Contact Information:**
**Financial Assistance:**
- Medical Oncology: 410-502-1304 or 410-955-8995
- Radiation Oncology: 410-614-1358 or 410-502-1643
**Student Financial Support:**
- Undergraduate Students: 410-516-8028
- Graduate Students: Visit the SEAM contact page for a dedicated adviser.
What insurance does Johns Hopkins University/Sidney Kimmel Cancer Center accept?
The Johns Hopkins University/Sidney Kimmel Cancer Center accepts a variety of insurance plans, such as Aetna, CareFirst BlueCross BlueShield, Cigna Healthcare, and UnitedHealthcare, among others. Coverage may vary based on insurance product type, employer benefit design, and physician location or specialty, so it's crucial to contact the insurer directly to confirm. Most Johns Hopkins Medicine hospitals and physicians participate with Medicare Advantage Plans, but patients should verify if an authorization and/or referral is necessary for services at specific facilities.
What awards or recognition has Johns Hopkins University/Sidney Kimmel Cancer Center received?
Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center, located in Baltimore, Maryland, was renamed in honor of philanthropist Sidney Kimmel following his $150 million donation for cancer research and patient care. The center is celebrated for its pioneering surgical treatments and extensive research in areas such as the genetic basis of colon cancer, cancer pain treatment, gene therapy, and innovative therapies for breast cancer. It has also gained acclaim for its researchers being named to the National Academy of Inventors, underscoring their significant contributions to science and society.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.